Breaking News Instant updates and real-time market news.

MS

Morgan Stanley

$46.59

0.08 (0.17%)

, JPM

JPMorgan

$90.89

-0.31 (-0.34%)

07:34
07/22/17
07/22
07:34
07/22/17
07:34

Big bank profits could be lifted 30% by deregulation, Barron's says

While a major overhaul is unlikely, recent proposals by the Treasury Department to ease the regulatory burden on banks and support greater lending may lead to some changes, Andrew Bary writes in this week's edition of Barron's. Big banks, such as Morgan Stanley (MS), JPMorgan (JPM), Goldman Sachs (GS), Citigroup (C), State Street (STT), and BNY Mellon (BK), could get a cumulative earnings boost averaging 30% if a series of regulatory-relief actions take place, the report noted, citing a report issued by KBW analysts Brian Kleinhanzl and Michael Brown.Reference Link

MS

Morgan Stanley

$46.59

0.08 (0.17%)

JPM

JPMorgan

$90.89

-0.31 (-0.34%)

GS

Goldman Sachs

$220.18

-2.12 (-0.95%)

C

Citi

$66.00

-0.36 (-0.54%)

STT

State Street

$90.99

0.12 (0.13%)

BK

BNY Mellon

$53.36

-0.55 (-1.02%)

  • 25

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 01

    Aug

  • 01

    Aug

  • 12

    Oct

  • 17

    Oct

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

MS Morgan Stanley
$46.59

0.08 (0.17%)

06/02/17
NOMU
06/02/17
NO CHANGE
NOMU
Goldman Sachs, Morgan Stanley Q2 EPS estimates lowered at Nomura Instinet
Nomura Instinet analyst Steven Chubak cut his Q2 EPS estimate for Goldman Sachs (GS) to $3.50 from $4.04 and lowered his Q2 EPS estimate for Morgan Stanley (MS) to 77c from 86c. The consensus EPS estimates for Goldman and Morgan Stanley are $3.92 and 84c, respectively. Chubak says that Goldman has been hurt by "weaker trading and more pronounced (investment banking) declines," while Morgan Stanley is experiencing "softer" investment banking results and "more pronounced quarter-over-quarter" fixed income declines. He keeps a Neutral rating on Goldman and a Buy rating on Morgan stanley.
06/28/17
FBCO
06/28/17
NO CHANGE
Target $47
FBCO
Neutral
Morgan Stanley estimates lowered at Credit Suisse
Credit Suisse analyst Susan Roth Katzke lowered her estimates for Morgan Stanley to reflect the current low volume/low volatility trading environment. She maintains a Neutral rating and $47 price target on the stock.
06/09/17
RBCM
06/09/17
NO CHANGE
RBCM
House financial reform bill unlikely to advance in Senate, says RBC Capital
RBC Capital analyst Gerard Cassidy says that the financial regulation reform bill passed yesterday by the House would help the banking sector but probably won;t be passed by the Senate. Large publicly traded banks include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC).
06/26/17
MACQ
06/26/17
NO CHANGE
Target $51
MACQ
Outperform
Macquarie says to buy Morgan Stanley at Macquarie
Morgan Stanley analyst David Konrad recommends buying Morgan Stanley today following DFAST results and recent share underperformance. The analyst believes results came in better than expected and sees additional room for buybacks of up to $5.5B from a previous estimate of $4.9B. Konrad rates shares an Outperform with a $51 price target.
JPM JPMorgan
$90.89

-0.31 (-0.34%)

07/11/17
BARD
07/11/17
NO CHANGE
BARD
Big bank set-up not great, would sell into extended rally, says Baird
Baird analyst David George does not see a great set-up for money-center banks heading into Q2 earnings. He said the trade looks crowded and he would be a seller into an extended rally. George said the risk/reward is less attractive following the sector's most recent rally as economic growth remains muted and the pace of NIM expansion may slow. George believes the biggest potential catalyst would be a gradual steepening of the yield curve and pick-up on loan growth.
07/06/17
GSCO
07/06/17
INITIATION
Target $93
GSCO
Neutral
JPMorgan initiated with a Neutral at Goldman Sachs
Goldman analyst Richard Ramsden resumed coverage on JPMorgan with a Neutral and a $93 price target saying it is a best-in-class franchise with a premium multiple.
07/06/17
07/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Nike (NKE) initiated with an Outperform at Raymond James. 2. JPMorgan (JPM) initiated with a Neutral at Goldman Sachs. 3. At Home Group (HOME) initiated with a Buy at SunTrust. 4. Logitech (LOGI) initiated with a Buy at Citi. 5. Medtronic (MDT) initiated with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/29/17
FBCO
06/29/17
NO CHANGE
Target $102
FBCO
Outperform
JPMorgan price target raised to $102 after CCAR review at Credit Suisse
Factoring in a share repurchase authorization for the 2017 CCAR cycle that she notes was 15% above her forecast and carrying through a higher rate of capital return into 2018, Credit Suisse analyst Susan Roth Katzke raised her price target on JPMorgan shares to $102 from $99 after the bank received Fed approval for its CCAR plan. The analyst keeps an Outperform rating on JPMorgan.
GS Goldman Sachs
$220.18

-2.12 (-0.95%)

07/19/17
OPCO
07/19/17
NO CHANGE
Target $256
OPCO
Outperform
Goldman Sachs price target raised to $256 from $251 at Oppenheimer
Oppenheimer analyst Chris Kotowski raised his price target for Goldman Sachs to $256 from $251 as he still thinks there is a "reasonable probability" of a FICC rebound once long-term rates go up and thinks the market is awarding a near zero value to this. The analyst reiterates an Outperform rating on the shares.
07/19/17
KBWI
07/19/17
DOWNGRADE
KBWI
Market Perform
Goldman Sachs downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl downgraded Goldman Sachs to Market Perform from Outperform and cut his price target for the shares to $230 from $260. The analyst sees a weakening revenue outlook following the investment bank's Q2 results.
06/28/17
FBCO
06/28/17
NO CHANGE
Target $240
FBCO
Outperform
Goldman Sachs price target raised to $240 from $230 at Credit Suisse
Credit Suisse analyst Susan Roth Katzke lowered her 2017 estimates for Goldman Sachs to reflect the current low volume/low volatility trading environment. However, assuming capital markets growth follows macroeconomic growth and the company realizes incremental operating leverage, she increased her 2018 and 2019 estimates for Goldman. Katzke increased her price target on Goldman shares to $240 from $230 and keeps an Outperform rating on the stock.
07/19/17
07/19/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AMC Entertainment (AMC) downgraded to Equal Weight from Overweight at Barclays with analyst Kannan Venkateshwar saying he sees increased risk after China indicated over the weekend that the government has blocked banks from funding AMC's parent, Chinese real estate conglomerate Dalian Wanda. 2. Chipotle (CMG) downgraded to Market Perform from Outperform at BMO Capital and Wells Fargo. 3. Goldman Sachs (GS) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Brian Kleinhanzl saying he sees a weakening revenue outlook following the investment bank's second quarter results. 4. PayPal (PYPL) downgraded to Hold from Buy at SunTrust with analyst Andrew Jeffrey citing valuation, "long-term competitive risk, and uncertain Venmo monetization." 5. First Solar (FSLR) downgraded to Hold from Buy at Standpoint Research with analyst Ronnie Moas saying the stock is fairly valued after jumping 70% over the past three months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
C Citi
$66.00

-0.36 (-0.54%)

07/17/17
FBCO
07/17/17
NO CHANGE
Target $72
FBCO
Outperform
Citi price target raised to $72 from $64 at Credit Suisse
Credit Suisse analyst Susan Roth Katzke raised her price target for Citi to $72 from $64 following a better than expected Q2. The analyst reiterates an Outperform rating on the shares.
07/11/17
07/11/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Blue Apron (APRN) initiated with a Sell rating and $2.00 price target at Northcoast. 2. Cheesecake Factory (CAKE) initiated with an Outperform at Wedbush. 3. Graphic Packaging (GPK) initiated with a Buy at DA Davidson. 4. Masimo (MASI) initiated with a Buy at Stifel. 5. Citi (C) initiated with a Hold at HSBC. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/17
HSBC
07/11/17
INITIATION
Target $71
HSBC
Hold
Citi initiated with a Hold at HSBC
HSBC analyst Alevizos Alevizakos initiated Citi with a Hold and a $71 price target saying higher profitability and buybacks appear reflected in valuation.
06/09/17
06/09/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Zynga (ZNGA) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Brian Nowak saying the company's in-game innovation, starting with Poker, is resulting in higher engagement and monetization. 2. Citi (C) upgraded to Neutral from Sell at UBS with analyst Saul Martinez saying he sees an improved risk/reward at current share levels. Global growth "looks resilient," protectionist policies have not emerged, and the path forward for structural reforms in the U.S. "is not as clear." 3. Comerica (CMA) upgraded to Outperform from Market Perform at FBR Capital. 4. Camping World (CWH) upgraded to Buy from Neutral at Goldman Sachs with analyst David Tamberrino saying he expects growth to continue despite late-cycle concerns. 5. Humana (HUM) upgraded to Buy from Hold at Argus with analyst David Toung saying he is upbeat about its growth outlook following the termination of its merger deal with Aetna (AET). This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
STT State Street
$90.99

0.12 (0.13%)

06/28/17
GSCO
06/28/17
UPGRADE
Target $100
GSCO
Conviction Buy
State Street upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman analyst Alexander Blostein added State Street to the Conviction Buy List and increased its price target to $100 from $92 saying pre-tax margin targets look conservative, providing confidence in above consensus estimates. The analyst estimates fee growth grew 4%+ quarter-over-quarter in Q2 due to a favorable fee mix shift amid non-US equities outperformance and flows accelerated into the company's higher-fee ETFs.
06/05/17
UBSW
06/05/17
UPGRADE
Target $92
UBSW
Buy
State Street upgraded to Buy from Neutral at UBS
UBS analyst Brennan Hawken upgraded State Street to Buy and raised his price target for the shares to $92 from $86. The analyst believes investor concerns about increased competitive pressure has brought an attractive buying opportunity. After meeting with management, Hawken has greater confidence in the earnings outlook for the company's European business.
05/26/17
05/26/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Immunomedics (IMMU) initiated with an Outperform at Cowen. 2. Sherwin-Williams (SHW) initiated with a Hold at Jefferies. 3. State Street (STT) reinstated with a Neutral at BofA/Merrill. 4. Zoetis (ZTS) initiated with a Buy at CL King. 5. BioDelivery Sciences (BDSI) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/26/17
BOFA
05/26/17
INITIATION
Target $88
BOFA
Neutral
State Street reinstated with a Neutral at BofA/Merrill
BofA/Merrill analyst Michael Carrier reinstated coverage on State Street with a Neutral and a $88 price target citing its lower growth outlook.
BK BNY Mellon
$53.36

-0.55 (-1.02%)

05/26/17
BOFA
05/26/17
INITIATION
Target $49
BOFA
Underperform
BNY Mellon reinstated with an Underperform at BofA/Merrill
BofA/Merrill analyst Michael Carrier reinstated coverage on BNY Mellon with an Underperform and a $49 price target given low revenue growth outlook.
04/13/17
DBAB
04/13/17
NO CHANGE
DBAB
Deutsche recommends long BNY Mellon, short State Street pair trade
Ahead of earnings reports from the brokers, asset managers and exchanges, Deutsche Bank analyst Brian Bedell recommends a pair trade to go long BNY Mellon (BK) versus short State Street (STT), as he sees NY Mellon narrowly beating consensus while he expects State Street to post a slight miss and also predicts downward revisions to 2017. Bedell keeps a Buy rating on BNY Mellon and a Hold rating on State Street.
03/03/17
EVER
03/03/17
DOWNGRADE
Target $48
EVER
Underperform
BNY Mellon downgraded to Underperform from Hold at Evercore ISI
Evercore ISI changed its rating system to Outperform, In Line and Underperform. Analyst Glenn Schorr downgraded BNY Mellon saying shares will benefit less versus peers from lower taxes, higher loan growth better capital markets, and financial deregulation. Schorr expects Trust Banks to have ongoing fee compression in core custody, lower NIR rate leverage, and increased competition. Schorr maintained his $48.50 price target on BNY Mellon shares.
01/20/17
01/20/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Bristol-Myers (BMY) downgraded to Market Perform from Outperform at Cowen with analyst Steve citing the company's announcement that it is not pursuing an early regulatory filing of the Opdivo plus Yervoy combination in first-line treatment of non-small cell lung cancer. He cut his price target on Bristol shares to $65 from $85. 2. BNY Mellon (BK) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Brian Kleinhanzl citing lower expectations after the company's fourth quarter results missed his estimates. The analyst lowered his price target for the shares to $48 from $54. 3. Western Union (WU) downgraded to Sell from Neutral at Compass Point. 4. Teva (TEVA) downgraded to Neutral from Overweight at JPMorgan with analyst Chris Schott saying the generic operating environment remains challenging. 5. CSX (CSX) downgraded to Hold from Buy at Deutsche Bank with analyst Amit Mehrotra citing valuation following yesterday's 23% rally. The stock is within 5% of the analyst's "Blue Sky" scenario and above his unchanged price target of $42. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

LYV

Live Nation

$48.15

-0.53 (-1.09%)

17:46
08/17/18
08/17
17:46
08/17/18
17:46
Hot Stocks
Live Nation CFO discloses sale of 40K shares of common stock »

Live Nation CFO Elizabeth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$72.63

0.21 (0.29%)

, XLU

Utilities SPDR

$54.50

0.25 (0.46%)

17:40
08/17/18
08/17
17:40
08/17/18
17:40
General news
Week ending ETF Scorecard: Consumer Staples outperforms, Energy skids »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$72.63

0.21 (0.29%)

XLU

Utilities SPDR

$54.50

0.25 (0.46%)

IYR

DJ US Real Estate Index Fund

$83.16

0.765 (0.93%)

XLP

Consumer Staples Sector SPDR

$55.02

0.39 (0.71%)

XLY

Consumer Discretionary Sector SPDR

$112.51

0.11 (0.10%)

XLB

S&P Select Materials SPDR

$58.41

0.41 (0.71%)

XLF

Financial Select Sector

$28.16

0.055 (0.20%)

XLV

Health Care Select Sector SPDR

$91.12

0.33 (0.36%)

XLK

Technology Select Sector SPDR

$73.17

0.14 (0.19%)

XLI

Industrial Select Sector SPDR

$76.26

0.47 (0.62%)

GLD

SPDR Gold Trust

$112.12

1.01 (0.91%)

SLV

iShares Silver Trust

$13.93

0.16 (1.16%)

USO

United States Oil Fund

$13.70

0.065 (0.48%)

UNG

United States Natural Gas Fund

$24.18

0.295 (1.24%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.03

0.08 (0.09%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.97

0.11 (0.09%)

TLT

iShares 20+ Year Treasury Bond Fund

$120.99

0.16 (0.13%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.49

0.04 (0.04%)

SHY

iShares 1-3 Year Treasury Bond

$83.28

0.03 (0.04%)

IWD

iShares Russell 1000 Value

$126.16

0.6 (0.48%)

IWF

iShares Russell 1000 Growth

$150.80

0.27 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$112.12

1.01 (0.91%)

17:33
08/17/18
08/17
17:33
08/17/18
17:33
Hot Stocks
SPDR Gold Trust holdings fall to 772.24MT from 773.41MT »

This is the 5th…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDOT

Green Dot

$85.04

0.37 (0.44%)

17:30
08/17/18
08/17
17:30
08/17/18
17:30
Hot Stocks
Green Dot exec Dent sells 7,754 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SMSI

Smith Micro

$2.49

-0.01 (-0.40%)

17:17
08/17/18
08/17
17:17
08/17/18
17:17
Syndicate
Breaking Syndicate news story on Smith Micro »

Smith Micro files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDRA

ENDRA Life Sciences

$2.70

0.2 (8.00%)

17:14
08/17/18
08/17
17:14
08/17/18
17:14
Syndicate
Breaking Syndicate news story on ENDRA Life Sciences »

ENDRA Life Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$346.44

0.55 (0.16%)

17:10
08/17/18
08/17
17:10
08/17/18
17:10
Hot Stocks
Boeing awarded $152.5M U.S. Navy contract »

Boeing is awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$346.44

0.55 (0.16%)

17:09
08/17/18
08/17
17:09
08/17/18
17:09
Hot Stocks
Boeing awarded $217M Defense Department contract »

The Boeing Co has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLL

L3 Technologies

$210.37

0.56 (0.27%)

17:08
08/17/18
08/17
17:08
08/17/18
17:08
Hot Stocks
L3 Technologies awarded $240M Defense Department contract »

L-3 Communications was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSGX

Histogenics

$2.65

-0.05 (-1.85%)

17:06
08/17/18
08/17
17:06
08/17/18
17:06
Syndicate
Breaking Syndicate news story on Histogenics »

Histogenics files $75M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLD

Prologis

$67.45

1.79 (2.73%)

, DCT

DCT Industrial

$68.77

1.805 (2.70%)

16:58
08/17/18
08/17
16:58
08/17/18
16:58
Conference/Events
DCT Industrial to host special shareholder meeting »

Special Shareholder…

PLD

Prologis

$67.45

1.79 (2.73%)

DCT

DCT Industrial

$68.77

1.805 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLK

Westlake Chemical

$95.61

-1.33 (-1.37%)

16:56
08/17/18
08/17
16:56
08/17/18
16:56
Hot Stocks
Westlake Chemical expands share repurchase program by $150M »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 11

    Sep

SM

SM Energy

$27.38

0.17 (0.62%)

16:55
08/17/18
08/17
16:55
08/17/18
16:55
Recommendations
SM Energy analyst commentary at MUFG »

SM Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

PENN

Penn National

$33.04

0.86 (2.67%)

16:51
08/17/18
08/17
16:51
08/17/18
16:51
Hot Stocks
Penn National CEO acquires 100,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$173.78

-0.98 (-0.56%)

16:49
08/17/18
08/17
16:49
08/17/18
16:49
Periodicals
U.S. wants Facebook to help wiretap Messenger for criminal probe, Reuters says »

The U.S. government is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

  • 18

    Sep

WLK

Westlake Chemical

$95.61

-1.33 (-1.37%)

16:46
08/17/18
08/17
16:46
08/17/18
16:46
Hot Stocks
Westlake Chemical raises quarterly dividend 19% to 25c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 11

    Sep

EAST

Eastside Distilling

$7.40

-0.01 (-0.13%)

16:45
08/17/18
08/17
16:45
08/17/18
16:45
Syndicate
Breaking Syndicate news story on Eastside Distilling »

Eastside Distilling files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOV

Spark Networks

$12.80

-0.095 (-0.74%)

16:44
08/17/18
08/17
16:44
08/17/18
16:44
Syndicate
Spark Networks files to sell 515,416 ordinary shares for holders »

Including 222 ordinary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AHPA

Avista Healthcare Public Acquisition Corp.

$10.12

(0.00%)

16:42
08/17/18
08/17
16:42
08/17/18
16:42
Hot Stocks
Avista Healthcare Public Acquisition Corp., Organogenesis announce combination »

Avista Healthcare Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCF

TCF Financial

$25.84

0.17 (0.66%)

16:41
08/17/18
08/17
16:41
08/17/18
16:41
Hot Stocks
TCF Financial COO sells 77,725 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.A

Lionsgate

$22.95

-0.11 (-0.48%)

16:38
08/17/18
08/17
16:38
08/17/18
16:38
Recommendations
Lionsgate analyst commentary at Barrington »

Lionsgate price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

16:35
08/17/18
08/17
16:35
08/17/18
16:35
General news
Breaking General news story  »

Moody's cuts Turkey…

MSL

MidSouth Bancorp

$14.90

0.1 (0.68%)

16:32
08/17/18
08/17
16:32
08/17/18
16:32
Hot Stocks
MidSouth Bancorp says 'will carefully review' letter sent by Jacobs Asset Mgt. »

MidSouth Bancorp issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EME

EMCOR

$77.96

1.005 (1.31%)

16:31
08/17/18
08/17
16:31
08/17/18
16:31
Hot Stocks
Emcor CEO sells 23,434 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/17/18
08/17
16:30
08/17/18
16:30
Options
Preliminary option volume of 22.3M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.